Status:
COMPLETED
China Post-Market Clinical Follow-up of FACILLE®
Lead Sponsor:
SciVision Biotech Inc.
Conditions:
Dermal Filler
Hyaluronic Acid
Eligibility:
All Genders
18+ years
Brief Summary
The results showed that subjects tolerated the Sodium Hyaluronate Gel for Injection (FACILLE®) well, with no systemic AEs, SAEs, and unanticipated AEs and associated with high satisfaction and self-ev...
Eligibility Criteria
Inclusion
- Age 18 years or older of male or female;
- Have used or plan to use FACILLE® Sodium Hyaluronate Gel for Injection;
- Agree to participate and comply with the follow-up schedule of this study.
Exclusion
- With a history of hypersensitivity or allergy to hyaluronic acid or any component of the device;
- Other circumstances were judged to be unsuitable for participating in the study by the investigator.
Key Trial Info
Start Date :
December 14 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 12 2020
Estimated Enrollment :
1552 Patients enrolled
Trial Details
Trial ID
NCT05294562
Start Date
December 14 2016
End Date
May 12 2020
Last Update
March 24 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.